Author:
Kazmi Jacob S,Albarghouthy Nabila,Ramsaywak Randy
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group;Ben-Menachem E;Epilepsia,2000
2. Neuropharmacology of antiseizure drugs;Hakami T;Neuropsychopharmacol Rep,2021
3. The adverse effects profile of levetiracetam in epilepsy: a more detailed look;Mbizvo GK;Int J Neurosci,2014
4. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review;Steinhoff BJ;Epilepsy Behav,2021
5. Drug-induced rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management;Wen Z;Drug Discov Today,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献